NCT01131546View on ClinicalTrials.gov

Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

1,080

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Essential Hypertension
Interventions
DRUG

Levamlodipine besylate

Once daily, 7AM - 10AM

DRUG

Amlodipine maleate

Once daily, 7AM - 10AM

Trial Locations (1)

Unknown

Peking University People's Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Jiangsu Simcere Pharmaceutical Co., Ltd.

INDUSTRY